103 related articles for article (PubMed ID: 6413976)
1. Inhibition of muscle differentiation by trypanosoma cruzi.
Rowin KS; Tanowitz HB; Wittner M; Nguyen HT; Nadal-Ginard B
Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6390-4. PubMed ID: 6413976
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma cruzi: reversal of inhibition of host muscle differentiation after exposure to elevated temperatures.
Tanowitz HB; Rowin KS; Roistacher K; Nadal-Ginard B; Wittner M
Exp Parasitol; 1984 Dec; 58(3):307-13. PubMed ID: 6389169
[TBL] [Abstract][Full Text] [Related]
3. The interaction of myotropic and macrophagotropic strains of Trypanosoma cruzi with myoblasts and fibers of skeletal muscle.
Araújo Jorge TC; Barbosa HS; Moreira AL; De Souza W; Meirelles MN
Z Parasitenkd; 1986; 72(5):577-84. PubMed ID: 3535281
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase levels in skeletal muscle of mice infected with Trypanosoma cruzi.
Brennessel DJ; Wittner M; Braunstein V; Tanowitz HB
Am J Trop Med Hyg; 1985 May; 34(3):460-4. PubMed ID: 3923851
[TBL] [Abstract][Full Text] [Related]
5. Pathoimmune polymyositis induced in C3H/HeJ mice by Trypanosoma cruzi infection.
von Kreuter BF; Santos-Buch CA
Clin Exp Rheumatol; 1986; 4(1):83-9. PubMed ID: 3084149
[TBL] [Abstract][Full Text] [Related]
6. Infection of L6E9 myoblasts with Trypanosoma cruzi alters adenylate cyclase activity and guanine nucleotide binding proteins.
Morris SA; Bilezikian JP; Tanowitz H; Wittner M
J Cell Physiol; 1987 Oct; 133(1):64-71. PubMed ID: 3117806
[TBL] [Abstract][Full Text] [Related]
7. Mercaptopyridine-N-oxide, an NADH-fumarate reductase inhibitor, blocks Trypanosoma cruzi growth in culture and in infected myoblasts.
Turrens JF; Newton CL; Zhong L; Hernandez FR; Whitfield J; Docampo R
FEMS Microbiol Lett; 1999 Jun; 175(2):217-21. PubMed ID: 10386371
[TBL] [Abstract][Full Text] [Related]
8. Priming astrocytes with TNF enhances their susceptibility to Trypanosoma cruzi infection and creates a self-sustaining inflammatory milieu.
Silva AA; Silva RR; Gibaldi D; Mariante RM; Dos Santos JB; Pereira IR; Moreira OC; Lannes-Vieira J
J Neuroinflammation; 2017 Sep; 14(1):182. PubMed ID: 28877735
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2.
Colas RA; Ashton AW; Mukherjee S; Dalli J; Akide-Ndunge OB; Huang H; Desruisseaux MS; Guan F; Jelicks LA; Matos Dos Santos F; Nagajyothi J; Zingman MA; Reyes J; Weiss LM; Serhan CN; Tanowitz HB
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358332
[No Abstract] [Full Text] [Related]
10. Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells.
Benatar AF; García GA; Bua J; Cerliani JP; Postan M; Tasso LM; Scaglione J; Stupirski JC; Toscano MA; Rabinovich GA; Gómez KA
PLoS Negl Trop Dis; 2015; 9(10):e0004148. PubMed ID: 26451839
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi induces trophoblast differentiation: a potential local antiparasitic mechanism of the human placenta?
Liempi A; Castillo C; Duaso J; Droguett D; Sandoval A; Barahona K; Hernández A; Galanti N; Maya JD; Kemmerling U
Placenta; 2014 Dec; 35(12):1035-42. PubMed ID: 25315217
[TBL] [Abstract][Full Text] [Related]
12. Infection characteristics of an Ecuadorian Trypanosoma cruzi strain with reduced virulence.
Rowland E; Luo H; McCormick T
J Parasitol; 1995 Feb; 81(1):123-6. PubMed ID: 7876970
[TBL] [Abstract][Full Text] [Related]
13. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
Solana ME; Alba Soto CD; Fernández MC; Poncini CV; Postan M; González Cappa SM
Parasitology; 2009 May; 136(6):627-39. PubMed ID: 19366478
[TBL] [Abstract][Full Text] [Related]
14. Mammalian Target of Rapamycin Inhibition in
Rojas Márquez JD; Ana Y; Baigorrí RE; Stempin CC; Cerban FM
Front Immunol; 2018; 9():313. PubMed ID: 29515594
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi: effect of parasite subpopulation on murine pregnancy outcome.
Solana ME; Celentano AM; Tekiel V; Jones M; González Cappa SM
J Parasitol; 2002 Feb; 88(1):102-6. PubMed ID: 12053948
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta regulates pathology but not tissue CD8+ T cell dysfunction during experimental Trypanosoma cruzi infection.
Martin DL; Postan M; Lucas P; Gress R; Tarleton RL
Eur J Immunol; 2007 Oct; 37(10):2764-71. PubMed ID: 17823982
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte diffusible redox mediators control
Estrada D; Specker G; Martínez A; Dias PP; Hissa B; Andrade LO; Radi R; Piacenza L
Biochem J; 2018 Apr; 475(7):1235-1251. PubMed ID: 29438066
[TBL] [Abstract][Full Text] [Related]
18. Immunization of mice with a Trypanosoma cruzi-like strain isolated from a bat: predictive factors for involvement of eosinophiles in tissue damage.
Nascentes GA; Meira WS; Lages-Silva E; Ramírez LE
Vector Borne Zoonotic Dis; 2010 Dec; 10(10):989-97. PubMed ID: 20455782
[TBL] [Abstract][Full Text] [Related]
19. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
[TBL] [Abstract][Full Text] [Related]
20. A comparative pathological study of three strains of Trypanosoma cruzi in an experimental model.
de Diego JA; Penin P; del Rey J; Mayer R; Gamallo C
Histol Histopathol; 1991 Apr; 6(2):199-206. PubMed ID: 1802119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
